BDNF and prostate cancer: Overexpression of BDNF-AS transcripts in PSA negative and PSA positive prostate cancer cell lines (PC-3 and LNCaP, respectively) resulted in a lower proliferative rate and significantly decreased the invasive capability of prostate cancer cells [58].